NAVCO Pharmaceuticals Inc (NAV)
TSXV
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -185k | 0 | 0 | -1,000 | -347k |
| Pre Tax Income | -185k | -49k | -74k | -94k | -2.15M |
| Net Income | -185k | -49k | -74k | -94k | -2.15M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.041 | -0.011 | -0.016 | -0.02 | -0.053 |
| EBIT | -185k | 0 | 0 | -1,000 | -1.01M |
| EBITDA | -185k | 0 | 0 | -1,000 | -304k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
